Acousia Therapeutics GmbH to share key learnings and data from its lead candidate development programs clinical stage ACOU085 and late preclinical stage ACOU082 during four presentations at industry …
Acousia Therapeutics GmbH: Hearing loss company Acousia Therapeutics to present key learnings and data from lead development programs at US and European meetings in August and September finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
A neurotransmitter chemical linked to mosquito hearing could be targeted to disrupt male mosquitoes' ability to detect the precise buzz of nearby females.